Tipelukast

DB12435InvestigationalSmall molecule

Tipelukast is under investigation for the treatment of IPF and Idiopathic pulmonary fibrosis.

Chemical structure of Tipelukast
Formula / weight
C29H38O7S · 530.68 g/mol (avg)

Resolves to

Compound
UNII08379P260OCAS125961-82-2ChEMBLCHEMBL2104988PubChem9893228
Structure
InChIKeyKPWYNAGOBXLMSE-UHFFFAOYSA-NSMILESCCCC1=C(O)C(=CC=C1SCCCOC1=C(CCC)C(OCCCC(O)=O)=C(C=C1)C(C)=O)C(C)=O
Targets
P09917ALOX5

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Tipelukast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In